LEIDEN JEFFREY M sold VRTX
February 15, 2024 · Form 4 insider transaction
LEIDEN JEFFREY M sold 4,655 shares of Vertex Pharmaceuticals Incorporated at $419.16 per share, a transaction worth $1.95M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
4,655
Price
$419.16
Total value
$1.95M
InsiderLEIDEN JEFFREY M
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 15, 2024
Filing dateFebruary 16, 2024
Shares owned after17,896
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 08/04/2023.